Mark F Lew Selected Research

Mark F Lew Research Topics

Disease

20	Parkinson Disease (Parkinson's Disease) 12/2019 - 11/2005
11	Torticollis (Wryneck) 01/2021 - 11/2002
2	Dyskinesias (Dyskinesia) 07/2018 - 11/2005
2	Parkinsonian Disorders (Parkinsonism) 01/2017 - 05/2014
2	Disease Progression 02/2015 - 05/2014
2	Tremor (Tremors) 05/2014 - 12/2013
2	Hypokinesia (Bradykinesia) 05/2014 - 12/2013
2	Pain (Aches) 04/2010 - 11/2002
1	Constipation 01/2019
1	Deglutition Disorders (Dysphagia) 05/2017
1	Muscle Weakness 05/2017
1	Neck Pain (Cervicalgia) 05/2017
1	Abdominal Pain (Pain, Abdominal) 07/2015
1	Stroke (Strokes) 05/2014
1	Hypersensitivity (Allergy) 01/2011
1	Chorea (Rheumatic Chorea) 01/2011
1	Polycythemia Vera 01/2011
1	Disorders of Excessive Somnolence (Hypersomnia) 01/2010
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2010
1	Edema (Dropsy) 01/2010
1	Hallucinations (Hallucination) 01/2010
1	Huntington Disease (Huntington's Disease) 08/2008
1	Hemifacial Spasm 11/2002
1	Blepharospasm 11/2002
1	Strabismus (Squint) 11/2002
1	Dystonic Disorders (Writer's Cramp) 11/2002
1	Paralysis (Palsy) 11/2002
1	Nervous System Diseases (Neurological Disorders) 11/2002

Drug/Important Bio-Agent (IBA)

9	Levodopa (L Dopa)FDA LinkGeneric 07/2018 - 11/2005
7	abobotulinumtoxinA FDA Link 01/2021 - 07/2005
6	Carbidopa (Lodosyn)FDA LinkGeneric 07/2018 - 09/2007
4	rasagiline (Azilect)FDA Link 01/2017 - 03/2009
4	rimabotulinumtoxinB FDA Link 09/2012 - 11/2002
3	Botulinum Toxins (Botulinum Toxin)IBA 01/2021 - 11/2002
3	TabletsIBA 01/2019 - 11/2005
3	Selegiline (E250)FDA LinkGeneric 01/2010 - 11/2005
2	SynucleinsIBA 12/2019 - 01/2019
2	SuspensionsIBA 07/2018 - 04/2016
2	levodopa drug combination carbidopa (Nakom)FDA LinkGeneric 07/2018 - 04/2016
2	Pharmaceutical PreparationsIBA 05/2017 - 05/2014
2	Pramipexole (Mirapex)FDA LinkGeneric 01/2017 - 01/2010
2	TEMPOIBA 12/2013 - 06/2010
2	Type A Botulinum Toxins (Botox)FDA Link 07/2005 - 11/2002
1	Biomarkers (Surrogate Marker)IBA 12/2019
1	Proteins (Proteins, Gene)FDA Link 01/2019
1	squalamineIBA 01/2019
1	SaltsIBA 01/2019
1	NeurotoxinsIBA 05/2017
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2017
1	ioflupaneIBA 01/2017
1	CreatineIBA 02/2015
1	coenzyme Q10 (CoQ10)IBA 05/2014
1	AntioxidantsIBA 05/2014
1	entacapone (Comtan)FDA Link 11/2011
1	CatecholaminesIBA 01/2011
1	Antipsychotic Agents (Antipsychotics)IBA 01/2011
1	Dopamine (Intropin)FDA LinkGeneric 01/2011
1	amsonic acid (DAS)IBA 01/2010
1	ropinirole (Requip)FDA LinkGeneric 01/2010
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2010
1	Phosphotransferases (Kinase)IBA 11/2008
1	Leucine (L-Leucine)FDA Link 11/2008
1	Adenosine Triphosphate (ATP)IBA 08/2008
1	Adenosine Diphosphate (ADP)IBA 08/2008
1	Tolcapone (Tasmar)FDA Link 09/2007
1	Acetylcholine (Acetylcholine Chloride)FDA Link 11/2002

Therapy/Procedure

7	Therapeutics 02/2015 - 04/2007
2	Injections 01/2021 - 01/2021
2	Gastric Bypass (Roux-en-Y Gastric Bypass) 07/2018 - 04/2016
2	Drug Therapy (Chemotherapy) 07/2015 - 01/2011
1	Activities of Daily Living (ADL) 01/2017
1	Polypharmacy 07/2015